Prognostic value of chronic inflammatory cell infiltrates in Dukes stage B and C colorectal cancer.

Prognostic value of chronic inflammatory cell infiltrates in Dukes stage B and C colorectal cancer.

Bibliografski detalji
Glavni autori:	Christie, M, Prakash, S, Jorissen, R, Sakthianandeswaren, A, Gibbs, P, Lipton, L, Desai, J, Tie, J, Kerr, D, Sieber, O
Format:	Journal article
Izdano:	2010

Slični predmeti

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.
od: Jorissen, R, i dr.
Izdano: (2009)

Prognostic value of p53, hMLH1, hMSH2, MGMT and COX-2 in the QUASAR-1 Dukes' stage B colorectal cancer cohort
od: Jubb, A, i dr.
Izdano: (2002)

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.
od: Christie, M, i dr.
Izdano: (2013)

Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations.
od: Mouradov, D, i dr.
Izdano: (2013)

Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations
od: Mouradov, D, i dr.
Izdano: (2013)

Is sidedness prognostically important across all stages of colorectal cancer?
od: Kerr, D, i dr.
Izdano: (2016)

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
od: Tie, J, i dr.
Izdano: (2011)

KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer.
od: Tie, J, i dr.
Izdano: (2011)

Prognostic Value of Microvascular Density in Dukes A and B (T1–T4, N0, M0) Colorectal Carcinomas
od: Rafael Uribarrena A, i dr.
Izdano: (2009-01-01)

Low-viscosity Matrix Suspension Culture for Human Colorectal Epithelial Organoids and Tumoroids
od: Tao Tan, i dr.
Izdano: (2022-04-01)

Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor‐infiltrating lymphocyte levels
od: Tomotaka Ugai, i dr.
Izdano: (2022-11-01)

DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
od: Jorissen, R, i dr.
Izdano: (2008)

Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
od: Glaire, MA, i dr.
Izdano: (2019)

The duke /
od: 375070 Foley, Gaelen
Izdano: (2000)

The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.
od: Ali, R, i dr.
Izdano: (2011)

The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial
od: Ali Raghib, i dr.
Izdano: (2011-12-01)

The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers
od: Yinghao Cao, i dr.
Izdano: (2022-04-01)

Duke of desarraigo
od: Javier Marías
Izdano: (2002-11-01)

High Infiltration of CD203c+ Mast Cells Reflects Immunosuppression and Hinders Prognostic Benefit in Stage II-III Colorectal Cancer
od: Li J, i dr.
Izdano: (2023-02-01)

Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer
od: Chen J, i dr.
Izdano: (2022-02-01)

GJA1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Colorectal Cancer
od: Hu W, i dr.
Izdano: (2020-11-01)

Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa
od: J.M. Villadiego-Sánchez, M. Ortega-Calvo, R. Pino-Mejías, A. Cayuela, P. Iglesias-Bonilla, F. García-de la Corte, J.M. Santos-Lozano, José Lapetra-Peralta
Izdano: (2009-01-01)

The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer
od: Jiateng Zhong, i dr.
Izdano: (2022-05-01)

Inclusion of vasculature-related variables in the Dukes staging system of colon cancer.
od: Koukourakis, M, i dr.
Izdano: (2005)

Prognostic value of inflammatory and immune markers in resectable colorectal cancer
od: MA Yifei , LIANG Xinjun , WEI Shaozhong
Izdano: (2021-09-01)

Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer
od: Nannan Zhang, i dr.
Izdano: (2020-11-01)

Molecular Characterization of Somatic Alterations in Dukes’ B and C Colorectal Cancers by Targeted Sequencing
od: Shafina-Nadiawati Abdul, i dr.
Izdano: (2017-07-01)

Duke mathematical journal
Izdano: (1935)

What the duke desires /
od: Jeffries, Sabrina
Izdano: (2013)

On the Insignia of the Grand Duke
od: Eligijus Raila
Izdano: (2005-12-01)

DUKE ELLINGTON BOULEVARD
od: Antonio MUNOZ MOLINA
Izdano: (2010-03-01)

The Monocular Duke of Urbino
od: Stephen G. Schwartz, i dr.
Izdano: (2016-12-01)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of NLRC4 and CASP1 in Colorectal Cancer
od: Peng L, i dr.
Izdano: (2022-06-01)

Tumor Infiltration by OX40+ Cells Enhances the Prognostic Significance of CD16+ Cell Infiltration in Colorectal Cancer
od: Fabian Haak, i dr.
Izdano: (2020-02-01)

Testing the Duke Population Health Profile (Duke-PH) in a Sample of Community Health Center Patients
od: George R. Parkerson, i dr.
Izdano: (2019-09-01)

(Analysis of the proliferating cell nuclear antigen(PCNA) and Ki-67 as proliferating cell markers) Expressions in colorectal carcinoma at HUSM and its relationship with the duke staging system
od: Kamal, Meor Zamari Meor, i dr.
Izdano: (2001)

Prognostic Biomarker SPOCD1 and Its Correlation with Immune Infiltrates in Colorectal Cancer
od: Lin Gan, i dr.
Izdano: (2023-01-01)

CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer
od: Xueli Wang, i dr.
Izdano: (2023-05-01)

Patterns in haemoglobin levels over 10 years to predict diagnosis of colorectal cancer by Duke’s staging: preliminary findings using UK primary care routine blood test data
od: Virdee, P, i dr.
Izdano: (2018)

Patterns in haemoglobin levels over 10 years to predict diagnosis of colorectal cancer by Duke’s staging: preliminary findings using UK primary care routine blood test data
od: Virdee, P, i dr.
Izdano: (2018)